An Open labelled, Single arm, clinical study to Evaluate Efficacy and Safety of GRACE HING (Hing oil 15 mg) HPMC Capsules in the Treatment of Abdominal Pain and Functional Dyspepsia

TRA GRACE0 个研究点目标入组 15 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1. Subjects below 18 years and above 60 years of age are excluded from the study.
•2. Subjects with complaints of abdominal spasms due to other systemic diagnosis apart from Gastro-Intestinal systems such as
•renal calculi, gall bladder stones, etc, are excluded from the study.
•3. Subjects who are not willing to give informed consent are excluded from the study.
•4. Subjects with co morbidities such as; Type 2 Diabetes mellitus, hypothyroidism, Hypertension are excluded from the study.
•5.Subjects who have been diagnosed of chronic diseases such as cardiovascular diseases, cancer, respiratory conditions, orthopaedic conditions
•associated with early and late complications are excluded from the study
•6. Subjects who are associated with long tern usage of analgesics & who has pasthistory of Gastro-intestinal surgery are excluded from
•7. Subjects with gastro or duodenal ulcers and are also afflicted with dysphagia &odynophagia are excluded from the study.
•8. Subjects with persistent GI bleeding and frequent vomiting are excluded from the study.

发起方

TRA GRACE